Skip to main content

Adma Biologics, Inc 10-Q for FY2025 Q3

Adma Biologics, Inc. (ADMA)

10-Q 2025-11-05 For: 2025-09-30
View Original
Added on April 04, 2026

About this 10-Q

Adma Biologics, Inc filed this 10-Q on November 5, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$134.22M
up 12.0% from $119.84M a year earlier
Net income
$36.43M
up 1.4% from net income of $35.91M a year earlier
Diluted EPS
$0.15
unchanged from $0.15 a year earlier